What is Interpath Laboratory?
Interpath Laboratory is a prominent, family-owned clinical and anatomic pathology medical laboratory. It stands as the largest independent laboratory in the Pacific Northwest, renowned for delivering precise diagnostics, efficient blood draws, and comprehensive pathology services. The company prioritizes rapid turnaround times and cost-effectiveness without compromising on quality. Serving a diverse clientele including hospitals, clinics, and individual patients, Interpath Laboratory also offers direct-to-consumer lab testing via its online platform, InterpathDirect. Their operational philosophy centers on community needs, advanced technology, and personalized patient care to improve health outcomes.
How much funding has Interpath Laboratory raised?
Interpath Laboratory has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Interpath Laboratory
PPP
Public-Private Partnership
What's next for Interpath Laboratory?
The recent major strategic investment signals a pivotal phase for Interpath Laboratory, likely enabling expansion of its service offerings, technological advancements, and market reach. This capital infusion is expected to bolster its competitive position against larger healthcare conglomerates and further solidify its role as a key independent provider in the Pacific Northwest. Future initiatives may focus on enhancing its direct-to-consumer testing capabilities and optimizing its operational efficiency to maintain its commitment to quality and affordability.
See full Interpath Laboratory company page
